Your browser doesn't support javascript.
loading
Cancer health self-efficacy improvement in a randomized controlled trial.
Leach, Corinne R; Hudson, Shawna V; Diefenbach, Michael A; Wiseman, Kara P; Sanders, Amy; Coa, Kisha; Chantaprasopsuk, Sicha; Stephens, Robert L; Alfano, Catherine M.
Affiliation
  • Leach CR; American Cancer Society, Atlanta, Georgia.
  • Hudson SV; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Diefenbach MA; Northwell Health, Manhasset, New York.
  • Wiseman KP; National Cancer Institute, Rockville, Maryland.
  • Sanders A; ICF International, Fairfax, Virginia.
  • Coa K; ICF International, Fairfax, Virginia.
  • Chantaprasopsuk S; American Cancer Society, Atlanta, Georgia.
  • Stephens RL; American Cancer Society, Atlanta, Georgia.
  • Alfano CM; American Cancer Society, Atlanta, Georgia.
Cancer ; 128(3): 597-605, 2022 02 01.
Article in En | MEDLINE | ID: mdl-34668569
BACKGROUND: eHealth interventions can help cancer survivors self-manage their health outside the clinic. Little is known about how best to engage and assist survivors across the age and cancer treatment spectra. METHODS: The American Cancer Society conducted a randomized controlled trial that assessed efficacy of, and engagement with, Springboard Beyond Cancer, an eHealth self-management program for cancer survivors. Intent-to treat analyses assessed effects of intervention engagement for treatment (on-treatment vs completed) overall (n = 176; 88 control, 88 intervention arm) and separately by age (<60 years vs older). Multiple imputation was used to account for participants who were lost to follow-up (n = 41) or missing self-efficacy data (n = 1) at 3 months follow-up. RESULTS: Self-efficacy for managing cancer, the primary outcome of this trial, increased significantly within the intervention arm and for those who had completed treatment (Cohen's d = 0.26, 0.31, respectively). Additionally, participants with moderate-to-high engagement in the text and/or web intervention (n = 30) had a significantly greater self-efficacy for managing cancer-related issues compared to the control group (n = 68), with a medium effect size (Cohen's d = 0.44). Self-efficacy did not differ between the intervention and control arm at 3 months post-baseline. CONCLUSIONS: Study results suggest that cancer survivors benefit variably from eHealth tools. To maximize effects of such tools, it is imperative to tailor information to a priori identified survivor subgroups and increase engagement efforts.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Telemedicine / Cancer Survivors / Self-Management / Neoplasms Type of study: Clinical_trials Limits: Humans / Middle aged Language: En Journal: Cancer Year: 2022 Type: Article Affiliation country: Georgia

Full text: 1 Database: MEDLINE Main subject: Telemedicine / Cancer Survivors / Self-Management / Neoplasms Type of study: Clinical_trials Limits: Humans / Middle aged Language: En Journal: Cancer Year: 2022 Type: Article Affiliation country: Georgia